{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=standard+of+care+treatment&page=23", "query": { "intervention": "standard of care treatment", "page": 23 }, "page_size": 10 }, "pagination": { "page": 23, "page_size": 10, "total_count": 9584, "total_pages": 959, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=standard+of+care+treatment&page=24&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=standard+of+care+treatment&page=22&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T16:03:59.096Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05325112", "title": "Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "FFR-CT", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "HeartFlow, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2022-07-15", "completion_date": "2022-11-14", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-14T16:03:59.096Z", "location_count": 2, "location_summary": "Worcester, Massachusetts • Cleveland, Ohio", "locations": [ { "city": "Worcester", "state": "Massachusetts" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05325112" }, { "nct_id": "NCT04776967", "title": "Effect of Total Compression Time and Rate (Slope) on Incidence of Symptomatic ETD and MEB: A Phase II Prospective Study.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Eustachian Tube Dysfunction", "Middle Ear Barotrauma", "Middle Ear Disease", "Middle Ear; Injury", "Pressure Injury", "Ear Barotrauma" ], "interventions": [ { "name": "Hyperbaric Compression Profile", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 300, "start_date": "2014-09-08", "completion_date": "2021-02-28", "has_results": false, "last_update_posted_date": "2021-08-19", "last_synced_at": "2026-10-14T16:03:59.096Z", "location_count": 1, "location_summary": "Sleepy Hollow, New York", "locations": [ { "city": "Sleepy Hollow", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04776967" }, { "nct_id": "NCT07074756", "title": "A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Glioma", "Recurrent Glioma", "Recurrent Glioblastoma" ], "interventions": [ { "name": "Chemotherapy", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Internet-Based Intervention", "type": "OTHER" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Neurologic Examination", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Surveillance", "type": "BEHAVIORAL" }, { "name": "Propranolol", "type": "DRUG" }, { "name": "Imipramine", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER", "BEHAVIORAL" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 202, "start_date": "2025-09-12", "completion_date": "2028-08-31", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-14T16:03:59.096Z", "location_count": 2, "location_summary": "Jacksonville, Florida • Rochester, Minnesota", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07074756" }, { "nct_id": "NCT00085839", "title": "Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "Tarceva (Trademark) (erlotinib HCl, OSI-774)", "type": "DRUG" }, { "name": "Combination carboplatin and paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OSI Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 103, "start_date": "2004-02", "completion_date": "2007-03", "has_results": true, "last_update_posted_date": "2012-08-09", "last_synced_at": "2026-10-14T16:03:59.096Z", "location_count": 19, "location_summary": "Greenbrae, California • San Diego, California • Fort Lauderdale, Florida + 16 more", "locations": [ { "city": "Greenbrae", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00085839" }, { "nct_id": "NCT00444977", "title": "Enhancing Oral Health Care Use by HIV Positive Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Oral Health Care", "HIV Infections", "Mouth Diseases" ], "interventions": [ { "name": "Case-management linkage intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Lisa Metsch", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": "2005-04", "completion_date": "2009-12", "has_results": false, "last_update_posted_date": "2013-07-08", "last_synced_at": "2026-10-14T16:03:59.096Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00444977" }, { "nct_id": "NCT06677112", "title": "MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Endometrial Cancer" ], "interventions": [ { "name": "Selective surgical staging", "type": "PROCEDURE" }, { "name": "REFLEX", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Rachel Miller", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 625, "start_date": "2025-03-17", "completion_date": "2030-01", "has_results": false, "last_update_posted_date": "2025-11-13", "last_synced_at": "2026-10-14T16:03:59.096Z", "location_count": 1, "location_summary": "Lexington, Kentucky", "locations": [ { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT06677112" }, { "nct_id": "NCT07248228", "title": "Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Brain Metastases" ], "interventions": [ { "name": "MA-WBRT (Memory Avoidance Whole Brain Radiation Therapy (MA-WBRT))", "type": "RADIATION" }, { "name": "HA-WBRT (Hippocampal Avoidance Whole Brain Radiation Therapy (HA-WBRT))", "type": "RADIATION" }, { "name": "Memantine", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2026-07-09", "completion_date": "2028-11", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-10-14T16:03:59.096Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07248228" }, { "nct_id": "NCT05022472", "title": "Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Vaccine Refusal", "Covid19" ], "interventions": [ { "name": "COVID-19 Individual Awareness and Education.", "type": "BEHAVIORAL" }, { "name": "COVID-19 Community Outreach & Health Promotion.", "type": "BEHAVIORAL" }, { "name": "COVID-19 Individual Health Education & Linkages to Medical and Supportive Services.", "type": "BEHAVIORAL" }, { "name": "Pop-up community vaccination sites", "type": "BIOLOGICAL" } ], "intervention_types": [ "BEHAVIORAL", "BIOLOGICAL" ], "sponsor": "Britt Skaathun", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "16 Years to 99 Years" }, "enrollment_count": 1051, "start_date": "2021-07-16", "completion_date": "2024-03-29", "has_results": true, "last_update_posted_date": "2025-06-06", "last_synced_at": "2026-10-14T16:03:59.096Z", "location_count": 6, "location_summary": "Chula Vista, California • San Diego, California • San Ysidro, California", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05022472" }, { "nct_id": "NCT05863351", "title": "Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Renal Cell Carcinoma", "Stage IV Renal Cell Cancer AJCC v8" ], "interventions": [ { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Stereotactic Ablative Radiotherapy", "type": "PROCEDURE" }, { "name": "Systemic Therapy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "ECOG-ACRIN Cancer Research Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 472, "start_date": "2023-12-27", "completion_date": "2028-08-31", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-10-14T16:03:59.096Z", "location_count": 108, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Aurora, Colorado + 80 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Fort Collins", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05863351" }, { "nct_id": "NCT07059975", "title": "UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Acute Myeloid Leukemia", "Pediatric AML" ], "interventions": [ { "name": "Idarubicin Hydrochloride", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cytarabine (Ara-C)", "type": "DRUG" }, { "name": "Venetoclax", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Asparaginase Erwinia Chrysanthemi (recombinant)", "type": "DRUG" }, { "name": "Intrathecal triple", "type": "DRUG" }, { "name": "SOC", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "30 Years", "sex": "ALL", "summary": "1 Month to 30 Years" }, "enrollment_count": 36, "start_date": "2025-10-22", "completion_date": "2031-08", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-10-14T16:03:59.096Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07059975" } ] }